The new Center for Excellence in Diabetes will focus on research, clinical trials and prevention for a disease affecting about one in six people in the San Antonio area.

Several US celebrities have turned to Ozempic or Mounjaro, either to help manage Type 2 diabetes or to assist with weight loss. Their before-and-after results have sparked widespread public interest ...

The evolving relationship between GLP-1 medications and protein consumption presents both challenges and opportunities for ...

Pacific research partnership offers a glimpse of how the obesity drug boom could transform global health – and raise difficult questions in the process.

Because of their hormones and anatomy, women don’t experience heart disease the same way men do. Here’s what sets women’s heart health apart and why it matters.

Despite causing irreversible damage, high cholesterol can be hard to spot – here's what experts say you should watch out for.

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

While that Ozempic number is higher, it's been prescribed for a lot longer than Wegovy. Even so, the researchers found the ...

John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor ...

Forty state legislators have sent a letter to the Group Insurance Commission board warning about the public health risks involved with eliminating coverage for GLP-1 weight-loss drugs for obesity — a ...

Major medical organizations updated the cholesterol playbook for the first time in years, with new risk tools, lower targets and earlier treatment recommendations.